Charlotte Frisen

Title: Charlotte Frisen: Innovator in Synthetic Viruses

Introduction

Charlotte Frisen is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology through her innovative work on synthetic viruses. Her research focuses on developing compositions and methods that can produce an immune response, which has important implications for vaccine development.

Latest Patents

Charlotte Frisen holds a patent for her invention titled "Synthetic viruses and uses thereof." This patent relates to compositions and methods for producing an immune response or reaction, as well as to vaccines, kits, processes, cells, and their uses. More specifically, her invention utilizes synthetic viral particles to enhance or regulate immune responses in subjects. This approach aims to raise immune responses against selected antigens or epitopes, particularly focusing on both cellular and humoral immune responses.

Career Highlights

Throughout her career, Charlotte has worked at prestigious institutions, including Pierre and Marie Curie University. Her research has been pivotal in advancing the understanding of synthetic viral particles and their applications in immunology.

Collaborations

Charlotte has collaborated with notable colleagues in her field, including David Klatzmann and Jean-Loup Salzmann. These partnerships have further enriched her research and contributed to the development of innovative solutions in vaccine technology.

Conclusion

Charlotte Frisen is a trailblazer in the field of synthetic viruses, with her patent showcasing her commitment to advancing immunological research. Her work has the potential to significantly impact vaccine development and immune response regulation.